Ergotamine, 9,10-dihydro- en es it fr

Ergotamine, 9,10-dihydro- Brand names, Ergotamine, 9,10-dihydro- Analogs

Ergotamine, 9,10-dihydro- Brand Names Mixture

  • No information avaliable

Ergotamine, 9,10-dihydro- Chemical_Formula

C33H37N5O5

Ergotamine, 9,10-dihydro- RX_link

http://www.rxlist.com/cgi/generic2/dihyergmes.htm

Ergotamine, 9,10-dihydro- fda sheet

Ergotamine,_9,10-dihydro- FDA

Ergotamine, 9,10-dihydro- msds (material safety sheet)

Ergotamine,_9,10-dihydro- MSDS

Ergotamine, 9,10-dihydro- Synthesis Reference

No information avaliable

Ergotamine, 9,10-dihydro- Molecular Weight

583.678 g/mol

Ergotamine, 9,10-dihydro- Melting Point

No information avaliable

Ergotamine, 9,10-dihydro- H2O Solubility

No information avaliable

Ergotamine, 9,10-dihydro- State

Solid

Ergotamine, 9,10-dihydro- LogP

No information avaliable

Ergotamine, 9,10-dihydro- Dosage Forms

Liquid

Ergotamine, 9,10-dihydro- Indication

For the acute treatment of migraine headaches with or without aura and the acute treatment of cluster headache episodes.

Ergotamine, 9,10-dihydro- Pharmacology

Dihydroergotamine is indicated for the acute treatment of migraine headaches with or without aura and the acute treatment of cluster headache episodes. Dihydroergotamine binds with high affinity to 5-HT1Da and 5-HT1Db receptors. It also binds with high affinity to serotonin 5-HT1A, 5-HT2A, and 5-HT2C receptors, noradrenaline a2A, a2B and a receptors, and dopamine D2L and D3 receptors. The therapeutic activity of Dihydroergotamine in migraine is generally attributed to the agonist effect at 5-HT1D receptors.

Ergotamine, 9,10-dihydro- Absorption

Interpatient variable and may be dependent on the administration technique

Ergotamine, 9,10-dihydro- side effects and Toxicity

Side effects include abdominal pain, abnormal speech, coma, confusion, convulsions, hallucinations, increase and/or decrease in blood pressure, nausea, numbness, tingling, pain, and a bluish color of your fingersand toes, slowed breathing, vomiting

Ergotamine, 9,10-dihydro- Patient Information

PATIENT INFORMATIOn

Follow the link below to get detailed information before taking D.H.E. 45 (dihydroergotamine mesylate) Injection.

http://www.rxlist.com/cgi/generic2/dihyergmes_pi.htm

Ergotamine, 9,10-dihydro- Organisms Affected

Humans and other mammals